The Life Sciences Report Announces 19 Companies Selected

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
100
The Life Sciences Report Announces 19 Companies Selected for the 2017 Small-Cap Biotech Watchlist

SAN FRANCISCO, CA --(Marketwired - January 04, 2017) - Now in its fifth year, the 2017 Life Sciences Report Biotech Watchlist includes nineteen small-cap biotech companies selected by top analysts in the field, and will be presented at the Biotech Showcase in San Francisco on January 11.

Included in this article are: Actinium Pharmaceuticals Inc. ( NYSE MKT : ATNM ) Asterias Biotherapeutics Inc. ( NYSE MKT : AST )

The collection of small-cap biotechs on the 2017 Watchlist are developing therapies to address diverse indications including rare diseases, asthma, inflammatory bowel disease, spinal cord injury, hemophilia, and a number of cancers. The platforms are equally diverse, representing traditional biologics, cell therapies and vaccines. Watchlist companies include:

Actinium Pharmaceuticals Inc.: ~$55M market cap. Actinium is in a pivotal Phase 3 trial with its lead candidate, Iomab-B, a radioimmunotherapy used prior to a bone marrow transplant in relapsed and refractory acute myeloid leukemia patients over the age of 55. It also has a second radioimmunotherapy, Actimab-A, in clinical study.

Asterias Biotherapeutics Inc. : ~$226M market cap. This stem cell company is addressing two key markets: spinal cord injury and cancer, with a dendritic cell (DC) therapy using genetically engineered autologous and allogeneic stem cells.

Continue reading this article: 19 Companies Selected for the 2017 Small-Cap Biotech Watchlist

About Streetwise Reports - The Life Sciences Report

Investors rely on The Life Sciences Report to share investment ideas for the biotech, pharmaceutical, medical device, and diagnostics industries. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security.

DISCLOSURE:

The following companies mentioned are sponsors of Streetwise Reports: None. Streetwise Reports does not accept stock in exchange for its services. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security.

Please see the end of the article for the complete disclosure: 19 Companies Selected for the 2017 Small-Cap Biotech Watchlist

Contact Information: Carrie Beal Amaro Associate Publisher Email contact

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 10

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 20

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 24

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 22

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 20

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 11

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 14

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding F5 Inc.'s Stock Performance and Valuation

Updated Category News Views 180

Analyzing F5 Inc.'s Stock Metrics In today's market, F5 Inc. (NASDAQ: FFIV) is trading at $315.70 after experiencing a slight decrease of 0.48%. Interestingly, over the past month, the company has seen its stock rise by 5.50%, and in the last year, it has impressively increased by 58.08%. This growth prompts shareholders to contemplate whether the stock's current...

Continue Reading
Jeffs’ Brands Enters Strategic Agreement for Security Tech Expansion

Updated Category News Views 127

Exploring New Horizons: Jeffs’ Brands' Non-Binding MOU The 3D, AI-Powered Technology Screens 25,000 People Per Hour—Without Stopping Them In an exciting development for Jeffs' Brands Ltd (“Jeffs’ Brands” or the “Company”) (NASDAQ: JFBR, JFBRW), a leading data-driven e-commerce firm leveraging the Amazon Marketplace, the company has announced its wholly owned...

Continue Reading
Essential Tips for Managing Chronic Back Pain and Health

Updated Category News Views 94

Understanding Pain Awareness Month September signals National Pain Awareness Month, a significant time to shed light on the challenges and treatment options for managing pain. Chronic pain impacts millions worldwide, deeply affecting day-to-day life. In particular, lower back pain is alarming, affecting over 619 million people globally according to recent statistics....

Continue Reading
Nerivio® REN Wearable Receives Approval in China for Migraine Relief

Updated Category News Views 336

Pier 88 Health and Theranica Revolutionize Migraine Treatment Pier 88 Health, a pioneer in digital health, and Theranica have announced a significant advancement in migraine treatment. Their groundbreaking product, the Nerivio® REN wearable, is now approved by China's National Medical Products Administration (NMPA), marking a pivotal moment for those suffering from this...

Continue Reading
Join the Excitement of CARNIVALE 2026 at Grace Cathedral

Updated Category News Views 198

Experience the Vibrant CARNIVALE 2026 Celebration Grace Cathedral, the cherished Episcopal landmark, is proud to announce the return of its spectacular Mardi Gras gala, CARNIVALE 2026. This exciting event is scheduled for February 13, 2026, promising to be a grand festive evening filled with joy and celebration. The Theme: Noite de Carnaval This year's theme, Noite de...

Continue Reading